Kobayashi Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Kobayashi Pharmaceutical has a total shareholder equity of ¥204.8B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥267.5B and ¥62.7B respectively. Kobayashi Pharmaceutical's EBIT is ¥25.6B making its interest coverage ratio -35. It has cash and short-term investments of ¥79.8B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | -35x |
Cash | JP¥79.84b |
Equity | JP¥204.82b |
Total liabilities | JP¥62.66b |
Total assets | JP¥267.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: KBYP.F's short term assets (¥158.3B) exceed its short term liabilities (¥56.1B).
Long Term Liabilities: KBYP.F's short term assets (¥158.3B) exceed its long term liabilities (¥6.5B).
Debt to Equity History and Analysis
Debt Level: KBYP.F is debt free.
Reducing Debt: KBYP.F has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Debt Coverage: KBYP.F has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: KBYP.F has no debt, therefore coverage of interest payments is not a concern.